Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Acetazolamide impurity 2 (NSC 231656) is characterized as a minor impurity of the carbonic anhydrase inhibitor, Acetazolamide. This compound is relevant for quality control and assurance in pharmaceutical formulations, particularly for studies assessing the purity and stability of Acetazolamide. Its identification and quantification may facilitate research on drug efficacy and safety in various therapeutic applications. -
Drug Impurity
Pregabalin impurity 3 is a recognized impurity associated with the drug Pregabalin, which primarily targets voltage-gated calcium channels. This compound may play a role in understanding the metabolic pathways and degradation processes of Pregabalin. Research applications of Pregabalin impurity 3 include method development for impurity analysis in pharmaceuticals and exploring potential interactions that could affect drug safety and efficacy. -
Drug Intermediate
(3R,4R)-4-Fluoropyrrolidin-3-ol hydrochloride is a valuable drug intermediate that facilitates the synthesis of diverse active pharmaceutical compounds. This reagent serves as a key building block in medicinal chemistry, providing a crucial step in the development of various biologically active molecules. Its specific structural characteristics make it essential for research in drug discovery and development. -
Drug Intermediate
1-(Pyrrolidin-3-yl)-1H-1,2,4-triazole oxalate serves as a critical drug intermediate in the synthesis of various biologically active compounds. Its unique structure allows for the modification of pharmacophores, facilitating the development of novel therapeutic agents. This reagent is essential for research applications in medicinal chemistry and drug discovery. -
Drug Intermediate
Rolapitant Intermediate, chemically defined as (3R,7aR)-3-(tert-Butyl)-1-hydroxy-7a-vinyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one, serves as a critical drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This intermediate is essential in the development of compounds with potential applications in the prevention and management of nausea and vomiting in patients undergoing chemotherapy. Its role in medicinal chemistry facilitates the creation of innovative therapeutics targeting related conditions. -
Drug Intermediate
Cis-ethyl 4-(cyclopropylamino)cyclohexanecarboxylate serves as a drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. Its structure provides essential functional groups for further chemical modifications, making it valuable in the development of new therapeutics. This reagent is important for researchers engaged in medicinal chemistry and drug discovery. -
Drug Intermediate
Methyl (S)-(-)-N-Z-aziridine-2-carboxylate is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a versatile building block in the development of various bioactive molecules, facilitating the preparation of complex pharmaceuticals. Its unique structure allows for efficient incorporation into drug discovery processes, making it valuable for researchers engaged in medicinal chemistry and related fields. -
Drug Intermediate
3-Bromo-2-methyl-1H-Pyrrolo[2,3-b]pyridine serves as a crucial intermediate in the synthesis of diverse active pharmaceutical compounds. This heterocyclic compound is integral in the development of novel therapeutic agents and plays a significant role in medicinal chemistry research. Its unique structural properties facilitate the construction of complex molecular frameworks, making it an essential reagent in drug discovery and development. -
Drug Impurity
Rivaroxaban impurity 70 is a chemical impurity associated with the anticoagulant Rivaroxaban. This compound is primarily used in pharmaceutical research to investigate the safety, efficacy, and quality of Rivaroxaban formulations. Its characterization is essential for compliance with regulatory standards and the development of robust drug manufacturing processes. -
Drug Impurity
Pramipexole impurity 9 is a chemical impurity associated with Pramipexole, a dopamine D2 receptor agonist used in the treatment of Parkinson's disease and restless legs syndrome. This impurity is relevant for analytical studies and quality control in pharmaceutical development, particularly in assessing the purity of Pramipexole formulations. Its characterization aids in understanding the stability and metabolism of the primary compound, ensuring safety and efficacy in therapeutic applications. -
Drug Intermediate
1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine acetate serves as a vital drug intermediate, playing a significant role in the synthesis of diverse active pharmaceutical compounds. This compound's unique structural features allow it to facilitate various chemical reactions, making it essential for medicinal chemistry research and development. Its applications extend to the production of novel therapeutic agents, contributing to advancements in drug discovery and development. -
Drug Intermediate
1,3,5-Triiodo-2-methoxybenzene serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. Its unique chemical structure enables its use in organic synthesis and medicinal chemistry, facilitating the development of novel therapeutic agents. This reagent is instrumental in various research applications focused on exploring new pharmaceutical formulations and enhancing compound efficacy. -
Drug Intermediate
4-Chloro-7-fluoropyrrolo[1,2-a]quinoxaline is a chemical intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This compound is integral in drug discovery and development, particularly for creating novel therapeutic agents. Its structural properties enable further modifications leading to biologically active derivatives, making it valuable in medicinal chemistry research. -
Drug Intermediate
4,5-Dibromo-2-methylpyridazin-3-one serves as a crucial drug intermediate in synthetic chemistry. Its structural properties enable the formation of various active pharmaceutical ingredients, making it a valuable compound in drug development. Researchers utilize this reagent in the synthesis of bioactive molecules, contributing to advancements in medicinal chemistry and therapeutic interventions. -
Drug Intermediate
2-Amino-N-(pyridin-3-ylmethyl)benzamide serves as a crucial drug intermediate in the synthesis of various bioactive compounds. It can facilitate the development of pharmacologically active substances, expanding the potential for novel therapeutic agents. This compound is valuable in medicinal chemistry research aimed at exploring new drug formulations and optimizing existing ones. -
Drug Intermediate
N-(1-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide is a chemical intermediate utilized in the synthesis of diverse pharmacologically active substances. This compound exhibits essential structural attributes that facilitate the development of novel therapeutic agents. Its application in organic synthesis underscores its significance in medicinal chemistry and drug discovery efforts. -
Drug Impurity
Glycopyrronium impurity 6 is a chemical impurity associated with Glycopyrronium, a medication utilized for its anticholinergic properties. This impurity is relevant for quality control and analytical chemistry applications in pharmaceutical development. Its characterization is essential for ensuring the purity and efficacy of Glycopyrronium formulations in drug research and regulatory compliance. -
Drug Intermediate Control
Indole-3-amidoxime is a synthetic intermediate primarily utilized in the pharmaceutical synthesis of various bioactive compounds. Its unique chemical structure allows for efficient modification, making it a valuable tool in developing new drugs. Key applications include its role in the creation of drug candidates and in the study of metabolic pathways relevant to pharmacology. -
Drug Intermediate
2-Amino-5-nitro-N-(o-tolyl)benzamide is a chemical intermediate used in the synthesis of diverse bioactive compounds. Its structure facilitates the development of pharmaceuticals with potential applications in drug discovery and development. This reagent is essential for researchers focused on advancing therapeutic agents and exploring new medicinal pathways. -
Drug Intermediate
tert-Butyl 4-(hydroxymethyl)-5-methoxy-7-methyl-1H-indole-1-carboxylate serves as a versatile drug intermediate primarily utilized in the synthesis of active pharmaceutical ingredients. Its structural features contribute to diverse chemical transformations, enabling the development of various bioactive compounds. This reagent is valuable in medicinal chemistry and research applications aimed at exploring novel therapeutic agents. -
Drug Intermediate
(2S,4R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride serves as a crucial drug intermediate in the synthesis of diverse pharmacologically active compounds. This specific intermediate facilitates the development of novel therapeutic agents by enabling the modification of molecular structures. Its unique configuration may influence biological activity, making it an essential reagent for researchers in medicinal chemistry and drug development. -
Drug Intermediate
2-Chloro-3-nitro-5-(trifluoromethyl)benzoic acid acts as a valuable drug intermediate in the synthesis of diverse pharmaceutical compounds. Its structural features facilitate the modification and development of biologically active molecules, making it essential for chemical research and drug discovery applications. This compound supports the advancement of novel therapeutics through its proficient use in synthetic pathways. -
Drug Intermediate
4-Amino-N-(2-chlorophenyl)benzamide is a key drug intermediate utilized in the synthesis of various bioactive compounds. This compound serves as a versatile building block in pharmaceutical research and development, enabling the creation of diverse therapeutic agents. Its structural features contribute to the development of compounds with potential biological activity across multiple targets. -
Drug Intermediate
(S)-2-(1,4-Dibenzylpiperazin-2-yl)acetonitrile serves as a drug intermediate in the synthesis of numerous active pharmaceutical compounds. This versatile reagent is crucial for the development of therapeutic agents, particularly those targeting central nervous system disorders. Its role in chemical synthesis enhances the efficiency and efficacy of compound development in drug discovery research. -
Drug Impurity
Ramipril Impurity 10 is a byproduct of Ramipril, a well-known angiotensin-converting enzyme (ACE) inhibitor. This impurity serves as a critical reference standard in pharmaceutical quality control and formulation development. Its characterization is essential for ensuring the integrity and safety of Ramipril-containing formulations in various research applications. -
Drug Intermediate
5-(2-(4-Fluorophenyl)acetyl)-2,2-dimethyl-1,3-dioxane-4,6-dione serves as a critical drug intermediate in the synthesis of various bioactive compounds. Its structural features enable the development of pharmacologically relevant agents, facilitating research in medicinal chemistry and drug discovery. This compound is essential for the advancement of tailored therapeutic pathways and the investigation of novel chemical entities. -
Drug Intermediate
1,2-Dimethylimidazole is a nitrogen-containing compound primarily used as a drug intermediate in pharmaceutical synthesis. This reagent serves as a valuable building block in the production of various bioactive molecules. Its unique structural features and reactivity make it useful in the development of therapeutic agents and chemical probes for biological research applications. -
Drug Intermediate
Nonane-1,9-diol is a straight-chain aliphatic diol that serves as a valuable drug intermediate in synthetic organic chemistry. Its unique structure facilitates the development of various pharmaceutical compounds and biochemical applications. This reagent is crucial for researchers engaged in the design and synthesis of bioactive molecules. -
Drug Intermediate
4-Bromo-6-chloro-1H-benzimidazol-2-amine serves as a vital drug intermediate in the synthesis of numerous bioactive compounds. This compound possesses significant potential for facilitating the development of novel pharmaceuticals due to its structural characteristics. It is widely utilized in chemical research and drug discovery processes. -
Drug Intermediate
(R)-2,5-Dioxotetrahydrofuran-3-yl acetate is an important drug intermediate utilized in the synthesis of various active pharmaceutical ingredients. Its structural properties facilitate the formation of diverse bioactive molecules, making it valuable in medicinal chemistry and drug development. This compound is particularly useful for researchers focusing on the design and optimization of therapeutic agents. -
Drug Impurity
Norepinephrine tartrate impurity 33 is an identified impurity associated with the adrenergic neurotransmitter norepinephrine tartrate. This compound may be utilized in pharmaceutical development and quality control assays to assess the purity of norepinephrine formulations. Its presence and characterization are crucial for ensuring compliance with regulatory standards and maintaining the integrity of therapeutic preparations. -
Drug Intermediate
(R)-1-Boc-3-propylpiperazine is a versatile drug intermediate featuring the Boc protection at the nitrogen atom in the piperazine ring. This compound serves as a crucial building block in the synthesis of various pharmacologically active molecules. It is particularly useful in medicinal chemistry for the design and development of potential therapeutic agents targeting a wide range of diseases. -
Drug Intermediate
1-tert-Butyl-3-ethoxybenzene is a key drug intermediate utilized in the synthesis of various bioactive compounds. This reagent plays a vital role in medicinal chemistry and pharmaceutical development, facilitating the creation of innovative therapeutic agents. Its application extends to the modification of molecular structures aimed at enhancing biological activity and efficacy. -
Drug Intermediate
Dichlorodiphenylmethane serves as a valuable drug intermediate, primarily utilized in the synthesis of various organic compounds. Its applications extend across multiple industries, including pesticides, dyes, and pharmaceuticals. This compound is integral in the development of new chemical entities, showcasing its versatility in chemical research and development. -
Drug Intermediate
N-[5-(Methoxycarbonyloxy)-2,4-di(tert-butyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide serves as a crucial drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This compound is instrumental in the development of therapeutics, particularly those targeting specific biological pathways, enabling advancements in drug discovery and development. Its unique chemical structure allows for modifications that enhance ligand profiling and biological activity in related research applications. -
Drug Intermediate
2,5-Dioxopyrrolidin-1-yl 2-cyanoacetate serves as a crucial drug intermediate in the synthesis of numerous active pharmaceutical compounds. This versatile reagent assists in the development of pharmaceuticals through the introduction of specific functional groups. Its application in organic synthesis makes it a valuable tool for researchers in the drug discovery process. -
Drug Intermediate
4-Hydroxy-2-naphthoic acid serves as a vital intermediate in the synthesis of diverse pharmaceutical compounds. It possesses significant applications in drug development, particularly in the formation of active moieties that exhibit biological activity. This compound's versatility makes it an important reagent for researchers focused on medicinal chemistry and synthetic organic chemistry. -
Drug Intermediate
(5-Methylpyrazin-2-yl)methanamine acetate functions as a key drug intermediate in the synthesis of various pharmacologically active compounds. This compound is significant for its role in facilitating chemical reactions leading to the development of novel therapeutic agents. It is commonly utilized in medicinal chemistry for the preparation of targeted pharmaceuticals. -
Drug Intermediate
Methyl 3-hydroxy-4-nitrothiophene-2-carboxylate serves as a crucial drug intermediate in the synthesis of various active pharmaceutical compounds. Its unique structure supports diverse chemical modifications, enabling the development of therapeutics targeting a range of biological pathways. This reagent is integral in pharmaceutical research aimed at discovering new small-molecule drugs. -
Drug Intermediate
N7,N7-Dimethyl-3-m-tolylisoquinoline-1,7-diamine serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its chemical structure allows for reactivity that facilitates the development of novel therapeutic agents. This compound is particularly valuable in research applications focused on drug design and development within medicinal chemistry. -
Drug Intermediate
1-(1-Phenylethyl)piperazine hydrochloride serves as a key drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structure facilitates the modification of bioactive compounds, making it essential in medicinal chemistry and drug development research. The compound is particularly useful in studies focused on neuropharmacology and can aid in the design of receptor modulators. -
Drug Intermediate
3-Amino-5-hydroxybenzoic acid is an important drug intermediate with a role in the biosynthesis of ansamycin antibiotics, such as ansatrienin A and geldanamycin, in addition to the antitumor antibiotic mitomycin C. It may also function as an early intermediate in the shikimic acid pathway derived from glucose. This compound is instrumental in chemical research focused on antibiotic development and the exploration of biosynthetic pathways. -
Drug Impurity
Rivaroxaban impurity 71, also known as N-Methylphthalimide, is a chemical impurity associated with Rivaroxaban synthesis. It serves as a reference standard for quality control and analytical studies in pharmaceutical development. This compound is critical for ensuring the purity and safety of Rivaroxaban formulations, facilitating research on drug efficacy and stability. -
Drug Intermediate
Oxiran-2-ylmethyl 4-nitrobenzenesulfonate is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. Its unique chemical structure facilitates the formation of various derivatives, making it integral in medicinal chemistry research and the development of new therapeutic agents. This reagent is ideal for researchers exploring innovative synthetic pathways in drug development. -
Drug Intermediate
1,3-Dichloro-5-iodo-2-methoxybenzene is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. Its unique halogenation patterns enhance reactivity, facilitating the generation of complex molecular structures. This compound is essential in pharmaceutical research and development, contributing to the discovery of new therapeutic agents. -
Drug Impurity
Ribociclib impurity 5 is a specific impurity associated with Ribociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This compound serves important roles in the quality control and characterization of ribociclib formulations. Its presence may impact drug efficacy and safety profiles, making it relevant for pharmacological and toxicological studies. Researchers can utilize Ribociclib impurity 5 to ensure analytical rigor in drug development and formulation testing. -
Drug Impurity
Ribociclib impurity 3 is a known impurity associated with Ribociclib, an FDA-approved cyclin-dependent kinase (CDK) inhibitor. This compound serves as a valuable reference material for the characterization and quality control of Ribociclib formulations. It is essential for analytical research and development, particularly in pharmacokinetic studies and stability assessments of CDK inhibitors. -
Drug Intermediate
6-Deoxypenciclovir is a key drug intermediate involved in the synthesis of the antiviral prodrug Famciclovir. As an inactive metabolite, it serves as a proficient substrate for rabbit hepatic aldehyde oxidase, facilitating the production of the active form of penciclovir. This compound is invaluable in pharmaceutical research and development focused on antiviral therapies. -
Drug Intermediate
Allyl (11S,11aS)-11-((tert-butyldimethylsilyl)oxy)-8-hydroxy-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its structure enables the development of novel therapeutic agents, expanding research opportunities in medicinal chemistry. This reagent is essential for scientists aiming to enhance pharmacological efficacy through innovative compound design. -
Drug Intermediate
2-Amino-4-bromo-3-nitropyridine serves as a key drug intermediate in the synthesis of diverse pharmacologically active compounds. It possesses a unique molecular structure that facilitates its application in the development of target-specific therapeutics. This reagent is valuable for researchers aiming to explore new derivatives in medicinal chemistry and drug discovery.
